PITANGO HEALTHTECH
PITANGO HEALTHTECH is a Seed, Series A, Series B and Series C+ fund in the US and Israel writing $1M–$15M checks into AI, Healthcare, medical-devices, life-sciences, therapeutics, biopharma, diagnostics, food-tech and agri-tech.
- Stages
- Seed, Series A, Series B, Series C+
- Sectors
- AI, Healthcare, medical-devices, life-sciences, therapeutics, biopharma, diagnostics, food-tech, agri-tech
- Check size
- $1M–$15M
- Invests in
- US-wide, Israel
- Actively investing
- Yes
- Founded
- 1993
- Assets under management
- $325M
- Website
- pitango.com
Thesis
Pitango HealthTech is a venture capital fund dedicated to early-stage investments in the health technology sector, operating under the broader Pitango Venture Capital platform. With nearly three decades of healthcare investment experience, the fund targets companies transforming healthcare through data science, AI, and novel biological approaches. Their investment thesis spans digital health, medical devices, life sciences, therapeutics, biopharma, AI-driven healthcare, diagnostics, food-tech, and agri-tech, focusing on seed to commercial stages. Geographically, they primarily invest in Israel and the United States. Pitango HealthTech II had a first closing of $175 million in 2023, and the broader Pitango VC platform manages over $3 billion in AUM. The firm has raised approximately $300 million across two new early-stage funds, Pitango First and Pitango HealthTech, in late 2025. The specific AUM for Pitango HealthTech is reported as $325 million. Investment checks typically range from $1 million to $15 million.
Common questions
Does PITANGO HEALTHTECH invest at the Seed stage?
Yes. PITANGO HEALTHTECH lists Seed, Series A, Series B and Series C+ among the stages it invests in.
What check size does PITANGO HEALTHTECH write?
PITANGO HEALTHTECH writes $1M–$15M checks.
Where does PITANGO HEALTHTECH invest?
PITANGO HEALTHTECH invests in the US and Israel.